These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6622263)

  • 21. Effect of high 131I doses on the bone uptake and retention of 90Sr and 90Y.
    Walinder G; Feinstein RE; Gimeno EJ
    Acta Radiol Oncol; 1986; 25(4-6):255-60. PubMed ID: 3030053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine influences on the activity ratio of 90Y to 90Sr in the rat skeleton after incorporation of 90Sr.
    Stevenson AF
    Acta Radiol Ther Phys Biol; 1977 Apr; 16(2):137-44. PubMed ID: 868580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The production and biological distribution of yttrium-90 labelled antibodies.
    Vaughan AT; Keeling A; Yankuba SC
    Int J Appl Radiat Isot; 1985 Oct; 36(10):803-6. PubMed ID: 4055089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Accumulation mechanism of radioisotopes for diagnosis of tumors (67ga-citrate, 169yb-citrate and 51cr-bleomycin)].
    Orii H
    Rinsho Hoshasen; 1973 Mar; 18(3):211-2. PubMed ID: 4122817
    [No Abstract]   [Full Text] [Related]  

  • 25. [Synthesis of tumor affinity label Yb-169- and Y-90- porphyrin complexes and animal experimental investigations with various Yb-169-porphyrins].
    Schomäcker K; Gaidouk MI; Rumyantseva VD; Fischer T; Löhr H; Salditt S; Liebenhoff S; Schicha H
    Nuklearmedizin; 1999; 38(7):285-91. PubMed ID: 10599068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.
    Uehara T; Jin ZL; Ogawa K; Akizawa H; Hashimoto K; Nakayama M; Arano Y
    Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Body retention of 169Yb-citrate and its excretion by 4 chelating agents].
    Zhu SP; Zhao JY; Su KY; Mo QZ; Wang GL
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):285-8. PubMed ID: 6240908
    [No Abstract]   [Full Text] [Related]  

  • 28. Invalidity of single-passage measurements of the extraction of bone-seeking tracers in rats and rabbits.
    Tothill P; Hooper G
    J Orthop Res; 1984; 2(1):75-9. PubMed ID: 6436457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the uptake of 51Cr and 64Cu beta-glycerophosphate complexes by tumours.
    Anghileri LJ
    Nucl Med (Stuttg); 1968 Oct; 7(3):266-78. PubMed ID: 5709696
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the tissue distribution of colloids of yttrium and lanthanum in experimental animals.
    MILES BJ; THOMSON AR
    Strahlentherapie; 1960; Suppl 45():102-19. PubMed ID: 13770636
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of bone-seeking metal salts on the biodistribution of tumor-seeking heavy metal complexes].
    Schomäcker K; Franke WG; Weiss S; Lindner L; Jantsch K; Shukla SK; Limouris GS
    Nuklearmedizin; 1993 Feb; 32(1):27-33. PubMed ID: 8464757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of zirconium citrate on the latent period of Sr89-induced bone cancer in mice.
    ZANDER-PRINCIPATI GE; KUZMA JF
    Radiat Res; 1960 Sep; 13():489-95. PubMed ID: 13846957
    [No Abstract]   [Full Text] [Related]  

  • 34. On the mechanisms of 67Ga and 59Fe uptake by tumors.
    Anghileri LJ; Crone MC; Thouvenot P; Brunotte F; Marchal C; Robert J
    Nuklearmedizin; 1983 Jun; 22(3):152-4. PubMed ID: 6578494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic substantiation of the use of 111In-citrate in bone marrow studies].
    Korsunskiĭ VN; Tarasenko IuI; Koval'chuk ND; Kosheleva IIu; Popov VI
    Med Radiol (Mosk); 1986 Jul; 31(7):48-52. PubMed ID: 3736386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Incorporation of radioactive citric acid into skeleton of white rat].
    LUSSIER JP
    Rev Can Biol; 1957 Dec; 16(4):434-44. PubMed ID: 13528184
    [No Abstract]   [Full Text] [Related]  

  • 37. Yttrium 90 in persistent synovitis of the knee - a single centre comparison. The retention and extra-articular spread of four 90-U radiocolloids.
    Gumpel JM; Beer JC; Crawley JC; Farran HE
    Br J Radiol; 1975 May; 48(569):377-81. PubMed ID: 1139094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Citric acid metabolism in the maxillodental system of rats of different ages after denervation ].
    Varava GN; Podorozhnaia RP; Genesina TI
    Stomatologiia (Mosk); 1988; 67(1):21-4. PubMed ID: 3163188
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.
    Ogawa K; Mukai T; Asano D; Kawashima H; Kinuya S; Shiba K; Hashimoto K; Mori H; Saji H
    J Nucl Med; 2007 Jan; 48(1):122-7. PubMed ID: 17204708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioactive colloidal solutions and suspensions for medical use.
    Mikheev NB
    At Energy Rev; 1976 Mar; 14(1):3-36. PubMed ID: 782479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.